UBS Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $305M | Sell |
643,482
-462,294
| -42% | -$233M | 0.05% | 420 |
|
|
2025
Q4 | $516M | Sell |
1,105,776
-496,823
| -31% | -$231M | 0.08% | 226 |
|
|
2025
Q3 | $683M | Buy |
1,602,599
+38,317
| +2% | +$14.9M | 0.11% | 176 |
|
|
2025
Q2 | $599M | Buy |
1,564,282
+456,114
| +41% | +$164M | 0.1% | 191 |
|
|
2025
Q1 | $383M | Buy |
1,108,168
+94,993
| +9% | +$30.6M | 0.07% | 279 |
|
|
2024
Q4 | $304M | Buy |
1,013,175
+543,849
| +116% | +$190M | 0.06% | 325 |
|
|
2024
Q3 | $191M | Buy |
469,326
+63,201
| +16% | +$23.1M | 0.04% | 437 |
|
|
2024
Q2 | $130M | Sell |
406,125
-156
| -0% | -$50.7K | 0.03% | 516 |
|
|
2024
Q1 | $136M | Buy |
406,281
+55,545
| +16% | +$17M | 0.03% | 505 |
|
|
2023
Q4 | $94.9M | Buy |
350,736
+4,709
| +1% | +$1.16M | 0.03% | 592 |
|
|
2023
Q3 | $85.1M | Buy |
346,027
+35,033
| +11% | +$9.59M | 0.03% | 568 |
|
|
2023
Q2 | $94.4M | Buy |
310,994
+59,793
| +24% | +$16.6M | 0.03% | 522 |
|
|
2023
Q1 | $66.2M | Buy |
251,201
+43,210
| +21% | +$11M | 0.02% | 642 |
|
|
2022
Q4 | $49.9M | Buy |
207,991
+73,614
| +55% | +$16.5M | 0.02% | 802 |
|
|
2022
Q3 | $24.7M | Sell |
134,377
-80,011
| -37% | -$15.9M | 0.01% | 1130 |
|
|
2022
Q2 | $36M | Sell |
214,388
-25,001
| -10% | -$5.37M | 0.01% | 936 |
|
|
2022
Q1 | $60M | Sell |
239,389
-116,928
| -33% | -$29.4M | 0.02% | 755 |
|
|
2021
Q4 | $91.5M | Buy |
356,317
+11,819
| +3% | +$2.89M | 0.03% | 643 |
|
|
2021
Q3 | $83.6M | Buy |
344,498
+23,200
| +7% | +$5.67M | 0.03% | 602 |
|
|
2021
Q2 | $66.4M | Sell |
321,298
-19,416
| -6% | -$3.96M | 0.02% | 693 |
|
|
2021
Q1 | $64.2M | Buy |
340,714
+66,808
| +24% | +$11.8M | 0.02% | 697 |
|
|
2020
Q4 | $45M | Buy |
273,906
+74,715
| +38% | +$10.9M | 0.02% | 837 |
|
|
2020
Q3 | $24.8M | Sell |
199,191
-334,394
| -63% | -$41.4M | 0.01% | 1033 |
|
|
2020
Q2 | $51.8M | Buy |
533,585
+243,972
| +84% | +$25.4M | 0.02% | 586 |
|
|
2020
Q1 | $26M | Sell |
289,613
-137,097
| -32% | -$17.8M | 0.01% | 848 |
|
|
2019
Q4 | $63.1M | Sell |
426,710
-14,323
| -3% | -$1.92M | 0.02% | 639 |
|
|
2019
Q3 | $53.1M | Buy |
441,033
+116,820
| +36% | +$15.1M | 0.02% | 665 |
|
|
2019
Q2 | $43.8M | Buy |
324,213
+57,216
| +21% | +$7.23M | 0.02% | 731 |
|
|
2019
Q1 | $34.8M | Buy |
266,997
+70,715
| +36% | +$9.5M | 0.01% | 828 |
|
|
2018
Q4 | $24.4M | Sell |
196,282
-81,020
| -29% | -$10.9M | 0.01% | 953 |
|
|
2018
Q3 | $38.6M | Buy |
277,302
+38,089
| +16% | +$4.74M | 0.02% | 809 |
|
|
2018
Q2 | $24.5M | Buy |
239,213
+112,007
| +88% | +$11.3M | 0.01% | 1039 |
|
|
2018
Q1 | $12.3M | Sell |
127,206
-23,216
| -15% | -$2.25M | 0.01% | 1521 |
|
|
2017
Q4 | $13.2M | Sell |
150,422
-61,576
| -29% | -$4.95M | 0.01% | 1509 |
|
|
2017
Q3 | $16.9M | Sell |
211,998
-133,475
| -39% | -$10.7M | 0.01% | 1218 |
|
|
2017
Q2 | $30.1M | Buy |
345,473
+38,045
| +12% | +$3.22M | 0.02% | 819 |
|
|
2017
Q1 | $27.4M | Buy |
307,428
+36,579
| +14% | +$3.05M | 0.01% | 840 |
|
|
2016
Q4 | $20M | Sell |
270,849
-44,823
| -14% | -$3.36M | 0.01% | 1025 |
|
|
2016
Q3 | $23.9M | Sell |
315,672
-6,834
| -2% | -$523K | 0.01% | 873 |
|
|
2016
Q2 | $24.8M | Sell |
322,506
-9,267
| -3% | -$732K | 0.02% | 814 |
|
|
2016
Q1 | $25.9M | Sell |
331,773
-9,130
| -3% | -$638K | 0.02% | 734 |
|
|
2015
Q4 | $23.1M | Sell |
340,903
-28,895
| -8% | -$2.02M | 0.02% | 869 |
|
|
2015
Q3 | $28.6M | Sell |
369,798
-4,349
| -1% | -$385K | 0.02% | 703 |
|
|
2015
Q2 | $33.9M | Sell |
374,147
-127,800
| -25% | -$10.2M | 0.02% | 683 |
|
|
2015
Q1 | $37.8M | Buy |
501,947
+26,931
| +6% | +$1.93M | 0.03% | 617 |
|
|
2014
Q4 | $34.9M | Buy |
+475,016
| New | +$33.4M | 0.02% | 691 |
|
Other funds holding HCA
VCM
VPM
UBS Group's HCA Position: Q1 2026 in Review
UBS Group reduced its HCA Healthcare (HCA) stake by 42% in Q1 2026, selling an estimated $233M and leaving 643,482 shares worth $305M. The position accounts for 0.05% of the portfolio, ranked #420.
UBS Group first reported a position in HCA in Q4 2014 and has held it in 46 quarters since. The position peaked at $683M in Q3 2025. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- UBS Group held 643,482 shares of HCA Healthcare worth $305M as of Q1 2026.
- UBS Group sold 462,294 HCA Healthcare shares in Q1 2026, an estimated $233M.
- HCA Healthcare made up 0.05% of UBS Group's portfolio in Q1 2026, its #420 holding.
- UBS Group first reported a position in HCA Healthcare in Q4 2014 and has held it in 46 quarters since.
- UBS Group's HCA Healthcare position peaked at $683M in Q3 2025.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.